January 1, 2007Journal of the CardioMetabolic Syndrome
The Metabolic Syndrome and Subclinical Carotid Atherosclerosis: The Northern Manhattan Study
Why the study?
Is the metabolic syndrome associated with an increased prevalence of subclinical carotid atherosclerosis in a multiethnic community population?
Population
1895 community residents from the Northern Manhattan Study, mean age 68.0+/-9.7 years, 59% women, multiethnic.
Comparison
Presence of Metabolic Syndrome (MetS) vs Absence of Metabolic Syndrome
Design
Cross-sectional
Authors
Discussion
Loading...
Member takes
Implication
Supports association with subclinical carotid atherosclerosis in multiethnic cohorts; leaves open causality and need for prospective outcome trials.
Structured PICO
Is the metabolic syndrome associated with an increased prevalence of subclinical carotid atherosclerosis in a multiethnic community population?
P
Population
1895 community residents from the Northern Manhattan Study, mean age 68.0+/-9.7 years, 59% women, multiethnic (25% black, 22% white, 51% Hispanic).
I
Intervention
Presence of Metabolic Syndrome (MetS)
C
Comparator
Absence of Metabolic Syndrome
O
Outcome
Presence of carotid plaque (subclinical atherosclerosis)surrogate
Metabolic syndrome is significantly associated with the presence of subclinical carotid atherosclerosis in a multiethnic cohort, highlighting its role in early vascular disease.
Cite This Study
Rundek et al. (2007) studied this question.